US3906950A - Inhaling device for powdered medicaments - Google Patents

Inhaling device for powdered medicaments Download PDF

Info

Publication number
US3906950A
US3906950A US45727074A US3906950A US 3906950 A US3906950 A US 3906950A US 45727074 A US45727074 A US 45727074A US 3906950 A US3906950 A US 3906950A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
inhaler
pair
pump
piece
comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Salvatore Cocozza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
I S F SpA
ISF SpA
Original Assignee
ISF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Abstract

An inhaling device for medicinal powders comprising a pump and an inhaler wherein the inhaler has a cavity formed by the interconnection of two compartments for holding a puncturable capsule containing a medicinal powder. Two sliding needles acting against the action of return springs pierce the capsule. In a preferred embodiment, the lower body portion of the inhaler is attached to the pump when in use and may be stored in ''''at rest'''' position when the inhaler is inverted into the pump.

Description

tinited States @ocozza 1 INHALING DEVICE FOR POWDERED MEDICAMENTS [75] lnventor: Salvatore Cocozza, Milan, Italy [73} Assignee: I.S.F. S.p.A., Milan, ltaly [22] Filed: Apr. 2, 1974 [21] Appl. No.: 457,270

[30] Foreign Application Priority Data Apr. 4, 1973 Italy 22576/73 June 22, 1973 Italy; 25698/73 [52] US. Cl. 128/266; 128/206 [51] Int. Cl. A61M 13/00; A61M 15/08 [58] Field of Search 128/266, 206, 208, 194, 128/265 [56] References Cited UNITED STATES PATENTS 2,307,986 l/1943 Bolt et al. 128/266 so ,2 20* y 2,517,482 8/1950 Hall 128/206 2,519,555 8/1950 128/266 2,581,182 l/1952 128/206 2,946,332 7/1960 Sacks 128/266 3507277 4/1970 Altounyan et al 128/208 3,669,113 6/1972 Altounyan et a1. 128/266 Primary Examiner-Aldrich F. Medbery Attorney, Agent, or Firm-Depaoli & OBrien [57] ABSTRACT An inhaling device for medicinal powders comprising a pump and an inhaler wherein the inhaler has a cavity formed by the interconnection of two-compartments for holding a puncturable capsule containing a medici nal powder. Two sliding needles acting against the action of return springs pierce the capsule. In a preferred embodiment, the lower body portion of the inhaler is attached to the pump when in use and may be stored in at rest position when the inhaler is inverted into the pump.

22 Claims, 6 Drawing Figures r L 56o US Patent Sept. 23,1975 Sh6t 1 01 2 3,906,950

US mm Sept. 23,1975 Sheet 2' 0f 2 3,9,%

INHALING DEVICE FOR POWDERED MEDICAMENTS BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to an inhaler for the administration of medicinal powders. More particularly, the inhaler relates to a traditional pump and an inhaler body having means for piercing a stored capsule containing medicinal powder.

2. Description of the Prior Art Inhalers are already known utilizing an elastic pump and a needle piercing a capsule which contains a me' dicinal substance; generally their working is not completely satisfactory as a result of rather complicated construction and cumbersome dimensions. In the in haler of the present invention, the above mentioned inconveniences have been practically eliminated, so that the inhaler is easily and quickly constructed and of reduced dimensions.

SUMMARY OF THE INVENTION It is the object of this invention to providean inhaler having simplified construction and reduced dimensions for use in combination with a conventional pump as an inhaling device for supplying medicinal powders to a body cavity.

It is another object to provide an inhaler having means for partial storage within the pump therefor.

It is an additional object to provide an inhaler having a means wheel to facilitate locking engagement with the pump.

It is a further object to provide an inhaler having a plurality of slidable alignment means. I

It is also an object to provide an inhaler having a spring-biased means for penetrating each end of a capsule stored therewithin.

In satisfaction of these objects and in accordance with the spirit of this invention, the inhaler contains a cavity-penetrating element. at one end thereof, through which air-entrained powder is forced out into a body cavity. a central element with an inside cavity for locating a capsule of medicinal powder therewithin. a pair of piercing devices for the endwise perforation of the capsule, and a base element having a polished surface interrupted by a ratchet wheel for connection with the pump. In more detail, the central element ofthe inhaler body is relatively fixed and formed by two components which are connected to each other, for example, by threading, bayonet insertion, and similar techniques. These components define a cavity therewithin, for placement of the capsule, and are slidably attached to a pair of relatively movable elements which hold piercing needles and which telescopically slide inside the two above-mentioned capsule holder components against the action of a pair of return springs.

The base element of the inhaler is so shaped that when the device is not in use, the inhaler body may be inverted into the pump, therby resulting in a noticeable reduction in overall size and a pleasant compact aspect of the whole which is aesthetically and practically favorable.

The inhaling device is adapted for delivering powdered substances in aerated form from a pierced capsule and comprises a pump and an inhaler, the inhaler comprising a relatively fixed central element formed by two connectable components and defining a cavity for reception of the capsule. and a pair of relatively moveable needle holder elements telescopically slidablc within the connectable components against the action of a pair of return springs. The components may be connected by screw means, a bayonet clutch means. or the like. Each of the pair of needle holder elements comprises a capsule-piercing needle. Each of the components is attached to a sleeve having an interior shoulder and each of the pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of the interior shoulders and a ncedle-piercing position against one of the connectable components. The inhaler also comprises a nose piece and a pump piece and one of the pair of holder elements is locked by friction to the noscpiecc and the other of the pair of needle holder elements may be locked against the piece by mi cro-ribs having saw teeth.

BRIEF DESCRIPTION OF THE DRAWINGS The inhaler which constitutes the present invention is shown in the accompanying drawings of the preferred embodiment in which:

FIG. 1 represents a side elevation of the assembled inhaling device comprising the inhaler inserted in a pump in operative condition.

FIG. 2 is a side elevation similar to FIG. I with the inhaler inverted in the pump to reduce the size of the device while partially stored therewithin.

FIG. 3 is a longitudinal section through the inhaler while in uncompressed condition.

FIG. 4 is a longitudinal section of the inhaler. similar to FIG. 3 but with the inhaler in a compressed condition, while in operative combination with a pump.

FIG. 5 is a cross-section taken along lines 55 of FIG. 3, and

FIG. 6 is a side elevation of the noseward component of the cavity-forming element.

DESCRIPTION OF THE PREFERRED EMBODIMENT Referring to the drawings. the inhaler 8 of this invention is employed in combination with a conventional pump 100 and comprises a central storage unit 10 having a central cavity defined by walls 13 within which a medicinal powder-container capsule 15 is inserted as needed by unscrewing a pair of compartments 20, 30. A pair of stop sleeves 60, 70 are non-slidably attached to the unit 10 and are outside of and in sliding relation to a pair of needle holders 40, containing a pair of capsule-puncturing needles 41, 51. The pair of stop sleeves 60, is also within and in sliding relation to a pair of end pieces, the nose piece and the pump piece 90, to which the holders 40, 50 are rigidly attached. The holders 40, 50 are biased away from the central cavity by a pair of springs 25, 35.

Coaxially disposed throughout the entire inhaler of this invention are a series of central holes for passage of air which enters the inhaler from the pump through base opening 98 and air passage 58, passes through the four air passages 59 shown in FIG. 5 to central hole 32 around pump needle 51, enters and passes through the punctured capsule 15 while entraining medicinal powder therefrom. travels past nose needle 41 through central hole 22, passes through the four air passages 49 into swirl compartment 83, and exits from the inhaler through discharge hole 81 in nosepiece 80.

The unit is formed by screwably connecting the nose compartment and the base compartment 30. The compartments 20, have coaxially disposed central holes 22, 32, annularly disposed spring wells 24, 34 which open away from the capsule 15, outer cylindrical recesses with surfaces 23, 33, and connecting screw threads 29, 39 by means of which the compartments 20, 30 are connected. Nose return spring 25 is seated within spring well 24, and pump return spring is seated within spring well 34.

Nose needle holder 40 and pump needle holder have somewhat l-l-shaped cross sections and comprise. respectively, annular fixed ends 46, 56 and annular sliding ends 47, 57 which rest against the springs 25, 35 within the spring wells 24, 34, as shown in FIG. 4. The holders 40, 50 also comprise four air passages 49, 59 which are separated by four radially spaced longitudinally disposed ribs, ribs 54 only being identified in FIG. 5. Each set of ribs 44, 54 supports a central portion containing a central needle recess which opens only toward the central cavity. The butt 42 of nose needle 41 and the butt 52 of pump needle 51 are each rigidly attached within these respective central needle recesses so that the respective needle points 43, 53 are coaxially aligned, centrally disposed within the central holes 22, 32, and in puncturing relationship to the ends of the capsule 15 within the range of compressibility of the springs 25, 35.

Additionally, the holders 40, 50 respectively comprise circumannular shoulders 45, 55 which extend outwardly exactly as far as the walls 23, 33 of the sleeve recesses of each compartment 20, 30. The circular sides 48, 58 of the shoulders 45, 55, opposite to the cavity for the capsule 15, function as a stop means in cooperation with the nose sleeve 60 and the pump sleeve 70, respectively, and the outer cylindrical surfaces of the shoulders 45, 55 are in sliding contact with the inner cylindrical surfaces 61, 71 of the sleeves 60, 70, thus functioning cooperatively therewith as an alignment means.

The nose and pump sleeve 60, respectively comprise elongated cylindrical portions, having outer sides 62, 72 and inner sides 61, 71, and inwardly extending interior shoulders 65, 75, having respective cavityfacing circular surfaces 66, 76, inner cylindrical surfaces 68, 78, and endward-facing circular surfaces 67, 77. The surfaces 68, 78 function as a sliding alignment means in cooperation with the cylindrical surfaces 46a, 56a of the fixed ends 46, 56 of the needle holders 40, 50. The inner side 61, 71 are non-slidably attached to the recessed outer surfaces 23, 33 and function cooperatively with the cylindrical outer surfaces of the shoulders 45, 55 as another sliding alignment means. Nonslidable attachment may be attained by means of suitable adhesive or by circumferential knurlings of the facing surfaces such as the knurlings 26 which are indicated in FIG. 6.

The nose piece 80 comprises a tapered penetration portion 82 through which passes the central discharge hole 81 therein. a skirt portion 84 which extends toward the cavity 15, and a stepped portion 85 therebetween. An annular recess coincides with the inner edge of the step portion 85 and penetrates longitudinally into the penetration portion 82. Into this annular recess, the fixed end 46 of the nose needle holder 40 is rigidly attached. as with an adhesive. The outer surface 62 of the nose sleeve 60 is in sliding engagement with the inner surface of the skirt 84 and functions cooperatively therewith as an alignment means.

The pump piece comprises an outer rim 91, a base 92 having an inwardly projecting circular lip to define the base opening 98, a circular lug 94 spaced pumpward from the edge of the rim 91, and circumferential serrations 97 along the inner surface of the base 92 and noseward of its circular lip. The lug 94 has a circular and arcuately receding surface 95, which acts as a storage stop means when the inhaler is in its inverted storage position shown in FIG. 2, and a circular and radially extending surface 96 which acts as an operational stop means when the inhaler is inserted into a conventional pump 100, as shown in FIGS. 1, 3, and 4. The serrations 97, which may be considered as ribbings, corrugations, or knurlings, are matched and engaged by similar serrations in the surfaces 56a.

The pump 100 typically has side walls 101, a circular top edge 102 which engages the surface 96 when the inhaler 8 is in operative position, and an air-containing interior 104 which should have sufficient depth to accommodate the inhaler 8 from the surface to the tip of the penetration portion 82 when the inhaler 8 is in stored position partially within the pump 100.

In summary, the inhaler 8 comprises three pairs of slidable alignment means:

I. inner cylindrical surfaces of skirt 84 and rim 91 in sliding contact with outer cylindrical surfaces 62, 72; 2. inner cylindrical surfaces 61, 71 in sliding contact with outer cylindrical surfaces of the shoulders 45, 55; and 3. inner cylindrical surfaces 68, 78 in sliding contact with outer cylindrical surfaces 46:1, 560. Because of these three pairs of slidable alignment means, the inhaler 8 possesses a high degree of trueness so that binding and wear are minimized.

In FIGS. 1-4, the profile of the cylindrical surface of the lower body portion of the inhaler 8, which is connected by friction with a pump of suitable dimensions and configuration, is polished and uniform and interrupted by the lug 94 where circular lines of contact 95 and 96 with the cylindrical surface represent the stop points in locking engagement with the pump 100 when the inhaler 8 is ready to use and when it is in storage position, respectively.

The inhaling device operates as follows:

Initially, the inhaler 8, inverted in the pump 100 (as shown in FIG. 2 is extracted therefrom and connected by friction locking in its upright position to the pump 100. Compartment 20 is then screwed off from compartment 30 and the capsule 15 of powder is inserted therein, after which nosepiece 80 and pumppiece 90 are moved towards one another, i.e., a contraction of the inhaler is caused along arrows AB, which creates two diametrally opposed perforations in capsule 15. Compare FIG. 1 with FIG. 4. Thereafter, it is possible to press the pump 100 to provoke the passage of the powder content of the capsule into a human cavity, such as nasal cavity or other cavities of the human body.

The present invention is not to be limited to the specific embodiment having the scope and advantages described hereinbefore, for various modifications can be made without departing from the spirit of the invention which should he understood asbeihglimited onlyiby the scope of the accompanying"claimst a 1. An inhalingdeyice, for-delivering powderedsubstances in aerated form from a pierced capsule, comprisinga pumpand. an inhaler, said inhalercomprising:

A. a, relatively fixed central element formed by two connectahle components and def ini ng a cavity. for reception of said capsule, and

B. a pair of relatively movcable ncc dleiholde'r ielm ments including piercing means mounted therein, which are: i IN 4 i r H l. telescopically slidable within said'corinectable components against the action of a pair of return springs and in the path of movement of air through said inhaler,

2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and

3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.

2. The inhaling device of claim 1 whereinsaid components are connected by screw means.

3. The inhaling device of claim 1 wherein each of said pair of needle holer elements comprises a capsulepiercing needle.

4. The inhaling device of claim 1 wherein each of said components is attached to a sleeve having an interior shoulder and each of said pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of said interior shoulders and a needle-piercing position against one of said conncctable components.

5. The inhaling device of claim 4 wherein said inhaler comprises a nose piece and a pump piece and one of said pair of said needle holder elements is locked by friction to said nose piece and the other of said pair of needle holder elements is locked against said pump piece by micro-ribs having saw teeth.

6. An inhaler for storing, entraining, and delivering powders in aerated condition, comprising;

A. a central storage unit for said powders,

B. a pair of needle holders including piercing means mounted therein which straddle said unit and are slidably connected thereto,

C. a nose piece which is non-slidably attached to one of said pair of needle holders,

D. a pump piece which is non-slidably attached to the other of said pair of needle holders, and

E. a longitudinally disposed air passage means extending from end to end of said inhaler, through said pump piece, said pair of needle holders, said central storage unit, and said nose piece, said nose piece and said pump piece ecah being longitudinally slidable toward said central storage unit to provide opposed piercing means for the central storage unit, whereby said powders are released.

7. The inhaler of claim 6 wherein said central storage unit comprises a pair of connectable compartments which define and contain. in combination, a cavity thcrewithin for storage of a capsule containing said powder.

8. The inhaler of claim 7 wherein each of said pair of conncctable compartments comprises an annular spring well within which a compression spring is seated.

'9. T he inhaler of claim.8 wherein each of said pair of needle holderscomprises a annular sliding end which is;slidably mounted within one of said annular spring wells andinengagement-with one .Of said springs.

10. The inhaler of claim 9.which further comprises a pair of stop:slceves which straddle said. unit and are non-slidably attached thereto.

11:. The inhaler of claim 10 wherein said pair of stop sleeves is in slidably circumferential and alignmentma'intaining relation to said pair of needle holder element's. 1 I

"12.The inhaler of claim 11- wherein each of said pair of stop sleeves has a cylindrical inner wall and said needle holders comprise circumanntilar shoulders which extend outwardly into slidable and alignmentmaintaining relation with said cylindrical inner walls of said stop sleeves.

13. The inhaler of claim 12 wherein each of said pair of needle holders additionally comprises an annular fixed end, one of said fixed ends being non-slidably attached to said nose piece and the other being nonslidably attached to said pump piece.

14. The inhaler of claim 13 wherein each of said pair of needle holders comprises a capsule-piercing needle, said needles being coaxially disposed in mutually opposed relationship and in straddling relationship to said capsule and being adapted to pierce said capsule when said springs are compressed by slidably moving said nose piece and said pump piece toward each other.

15. The inhaler of claim 14 wherein each of said stop sleeves additionally comprises an inwardly extending interior shoulder which extends into sliding engagement with exterior cylindrical surfaces of said fixed ends, as a sliding alignment means.

16. The inhaler of claim 15 wherein:

A. said nosepiece, said stop sleeves, and said central storage unit have a smaller exterior diameter than the exterior diameter of said pump piece, and

B. said pump piece comprises a circumferential and outwardly extending lug having an arcuately recedingsurface and a radially receding surface,

whereby said arcuately receding surface functions as a storage stop means, when said inhaler is inverted into a pump for storage by inserting said nose piece thereinto, and said radially receding surface functions as an operational stop means, when said inhaler is inserted into said pump by engaging said pump piece therewith.

17. The inhaler of claim 16 wherein said pump piece further has an exterior cylindrical surface which is polished and uniformly interrupted by a friction locking means for the mouthpiece of said pump.

18. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the surface normal to said means are friction locking points between said inhaler and said pump.

19. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the portions of said means have curved surfaces which are stop points for friction locking between said inhaler and said pump when said inhaling device is not in use.

20. The inhaling device of claim 5 wherein:

A. said nose piece and said. pump piece each comprises a skirt portion extending toward said cavity and having an inner cylindrical surface adapted for sliding contact; and

B. each said sleeve comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said skirt portions of said nose piece and said pump piece to form a first pair of slidable alignment means.

21. The inhaling device of claim wherein:

Apeach said sleeve, attached to one of said two conncctahle components. comprises an inner cylindrical surface adapted for sliding contact; and

B. each said outwardly disposed shoulder of said pair of needle holder elements comprises an outer cylindrical surface adapted for said sliding contact with one of said sleeves to form a second pair of slidable alignment means.

22. The inhaling device of claim 21 wherein:

A. each said interior shoulder of said sleeves attached to said two components comprises an inner cylindrical surface adapted for sliding contact: and

Bi each said needle holder element comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said interior shoulders to form a third slidable alignment means. said first, second. and third pairs of slidable alignment means imparting a high degree of trueness to said inhaler so that binding and wear are minimized.

Claims (24)

1. An inhaling device, for delivering powdered substances in aerated form from a pierced capsule, comprising a pump and an inhaler, said inhaler comprising: A. a relatively fixed central element formed by two connectable components and defining a cavity for reception of said capsule, and B. a pair of relatively moveable needle holder elements including piercing means mounted therein, which are: 1. telescopically slidable within said connectable components against the action of a pair of return springs and in the path of movement of air through said inhaler, 2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and 3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and
2. The inhaling device of claim 1 wherein said components are connected by screw means.
3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
3. The inhaling device of claim 1 wherein each of said pair of needle holer elements comprises a capsule-piercing needle.
4. The inhaling device of claim 1 wherein each of said components is attached to a sleeve having an interior shoulder and each of said pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of said interior shoulders and a needle-piercing position against one of said connectable components.
5. The inhaling device of claim 4 wherein said inhaler comprises a nose piece and a pump piece and one of said pair of said needle holder elements is locked by friction to said nose piece and the other of said pair of needle holder elements is locked against said pump piece by micro-ribs having saw teeth.
6. An inhaler for storing, entraining, and delivering powders in aerated condition, comprising; A. a central storage unit for said powders, B. a apir of needle holders including piercing means mounted therein which straddle said unit and are slidably connected thereto, C. a nose piece which is non-slidably attached to one of said pair of needle holders, D. a pump piece which is non-slidably attached to the other of said pair of needle holders, and E. a longitudinally disposed air passage means extending from end to end of said inhaler, through said pump piece, said pair of needle holders, said central storage unit, and said nose piece, said nose piece and said pump piece ecah being longitudinally slidable toward said central storage unit to provide opposed piercing means for the central storage unit, whereby said powders are released.
7. The inhaler of claim 6 wherein said central storage unit comprises a pair of connectable compartments which define and contain, in combination, a cavity therewithin for storage of a capsule containing said powder.
8. The inhaler of claim 7 wherein each of said pair of connectable compartments comprises an annular spring well within which a compression spring is seated.
9. The inhaler of claim 8 wherein each of said pair of needle holders comprises a annular sliding end which is slidably mounted within one of said annular spring wells and in engagement with one of said springs.
10. The inhaler of claim 9 which further comprises a pair of stop sleeves which straddle said unit and are non-slidably attached thereto.
11. The inhaler of claim 10 wherein said pair of stop sleeves is in slidably circumferential and alignment-maintaining relation to said pair of needle holder elements.
12. The inhaler of claim 11 wherein each of said pair of stop sleeves has a cylindrical inner wall and said needle holders comprise circumannular shoulders which extend outwardly into slidable and alignment-maintaining relation with said cylindrical inner walls of said stop sleeves.
13. The inhaler of claim 12 wherein each of said pair of needle holders additionally comprises an annular fixed end, one of said fixed ends being non-slidably attached to said nose piece and the other being non-slidably attached to said pump piece.
14. The inhaler of claim 13 wherein each of said pair of needle holders comprises a capsule-piercing needle, said needles being coaxially disposed in mutually opposed relationship and in straddling relationship to said capsule and being adapted to pierce said capsule when said springs are compressed by slidably moving said nose piece and said pump piece toward each other.
15. The inhaler of claim 14 wherein each of said stop sleeves additionally comprises an inwardly extending interior shoulder which extends into sliding engagement with exterior cylindrical surfaces of said fixed ends, as a sliding alignment means.
16. The inhaler of claim 15 wherein: A. said nosepiece, said stop sleeves, and said central storage unit have a smaller exterior diameter than the exterior diameter of said pump piece, and B. said pump piece comprises a circumferential and outwardly extending lug having an arcuately receding surface and a radially receding surface, whereby said arcuately receding surface functions as a storage stop means, when said inhaler is inverted into a pump for storage by inserting said nose piece thereinto, and said radially receding surface functions as an operational stop means, when said inhaler is inserted into said pump by engaging said pump piece therewith.
17. The inhaler of claim 16 wherein said pump piece further has an exterior cylindrical surface which is polished and uniformly interrupted by a friction locking means for the mouthpiece of said pump.
18. The inhaling device of claim 17 wherein the points of contacT between the cylindrical surface of the lower body portion and the surface normal to said means are friction locking points between said inhaler and said pump.
19. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the portions of said means have curved surfaces which are stop points for friction locking between said inhaler and said pump when said inhaling device is not in use.
20. The inhaling device of claim 5 wherein: A. said nose piece and said pump piece each comprises a skirt portion extending toward said cavity and having an inner cylindrical surface adapted for sliding contact; and B. each said sleeve comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said skirt portions of said nose piece and said pump piece to form a first pair of slidable alignment means.
21. The inhaling device of claim 20 wherein: A. each said sleeve, attached to one of said two connectable components, comprises an inner cylindrical surface adapted for sliding contact; and B. each said outwardly disposed shoulder of said pair of needle holder elements comprises an outer cylindrical surface adapted for said sliding contact with one of said sleeves to form a second pair of slidable alignment means.
22. The inhaling device of claim 21 wherein: A. each said interior shoulder of said sleeves attached to said two components comprises an inner cylindrical surface adapted for sliding contact; and B. each said needle holder element comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said interior shoulders to form a third slidable alignment means, said first, second, and third pairs of slidable alignment means imparting a high degree of trueness to said inhaler so that binding and wear are minimized.
US3906950A 1973-04-04 1974-04-02 Inhaling device for powdered medicaments Expired - Lifetime US3906950A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT2257673 1973-04-04
IT2569873 1973-06-22

Publications (1)

Publication Number Publication Date
US3906950A true US3906950A (en) 1975-09-23

Family

ID=26328226

Family Applications (1)

Application Number Title Priority Date Filing Date
US3906950A Expired - Lifetime US3906950A (en) 1973-04-04 1974-04-02 Inhaling device for powdered medicaments

Country Status (6)

Country Link
US (1) US3906950A (en)
JP (1) JPS5048782A (en)
BE (1) BE813143A (en)
DE (2) DE2415961A1 (en)
FR (1) FR2224175B1 (en)
GB (1) GB1436813A (en)

Cited By (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013075A (en) * 1974-07-15 1977-03-22 I.S.F. S.P.A. Inhalers and insufflators having a cutting means
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US4095596A (en) * 1976-11-26 1978-06-20 Smithkline Corporation Nasal inhaler
US4105027A (en) * 1975-06-13 1978-08-08 Syntex Puerto Rico, Inc. Inhalation device
US4116195A (en) * 1976-02-10 1978-09-26 Allen & Hanburys Limited Device for dispensing medicaments
US4240418A (en) * 1974-08-22 1980-12-23 Schering Aktiengesellschaft Apparatus for the inhalation of medicinal agents
US4338931A (en) * 1979-04-27 1982-07-13 Claudio Cavazza Device for the quick inhalation of drugs in powder form by humans suffering from asthma
US4446862A (en) * 1979-10-30 1984-05-08 Baum Eric A Breath actuated devices for administering powdered medicaments
US4620847A (en) * 1984-06-01 1986-11-04 Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov Device for administering powdered substances
US4645487A (en) * 1984-06-05 1987-02-24 Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov Device for administering powdered substances
US4884565A (en) * 1987-08-17 1989-12-05 Miat S.P.A. Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
US4889114A (en) * 1983-12-17 1989-12-26 Boehringer Ingelheim Kg Powdered pharmaceutical inhaler
US5033463A (en) * 1989-10-27 1991-07-23 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
US5152284A (en) * 1989-02-23 1992-10-06 Phidea S.P.A. Disposable inhaler with pre-pierced capsule
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5366122A (en) * 1991-08-27 1994-11-22 Ing. Erich Pfeiffer Gmbh & Co. Kg Dispenser for flowable media
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5460173A (en) * 1993-03-03 1995-10-24 Tenax Corporation Dry powder inhaler medicament carrier
US5488946A (en) * 1994-03-01 1996-02-06 Calhoun; Clifford A. Emergency breathing device for opening cartridges
WO1996012513A1 (en) * 1994-10-24 1996-05-02 Oxford Biosciences Limited Particle delivery
EP0761248A1 (en) * 1995-03-10 1997-03-12 Unisia Jecs Corporation Intranasal medicator
US5617845A (en) * 1990-08-30 1997-04-08 Boehringer Ingelheim Kg Inhalation device free from propellent gas
US5692496A (en) * 1995-08-02 1997-12-02 Innovative Devices, Llc Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5715811A (en) * 1994-05-26 1998-02-10 Unisia Jecs Corporation Inhaling type medicine administering device and using method therefor
US5752505A (en) * 1996-03-21 1998-05-19 Unisia Jecs Corporation Inhalation-type medicine delivery device
US5810004A (en) * 1995-10-09 1998-09-22 Unisia Jecs Corporation Medicator for a capsule filled with a powdered drug
US5823183A (en) * 1995-08-02 1998-10-20 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
WO1998058695A1 (en) * 1997-06-23 1998-12-30 Marco Cecchini Inhaling device
US5901703A (en) * 1995-02-06 1999-05-11 Unisia Jecs Corporation Medicine administering device for nasal cavities
US5988163A (en) * 1995-08-02 1999-11-23 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US6186141B1 (en) * 1996-05-10 2001-02-13 Glaxo Wellcome Inc. Unit dose dispensing device
US6209538B1 (en) * 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US6273086B1 (en) * 1998-02-06 2001-08-14 Unisia Jecs Corporation Inhalant medicator
US20010029947A1 (en) * 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US6341605B1 (en) * 1998-02-05 2002-01-29 Unisia Jecs Corporation Inhalant medicator
US20020134382A1 (en) * 2000-05-10 2002-09-26 Snow John M. Medicament container with same side airflow inlet and outlet and method of use
US6546929B2 (en) 1998-06-04 2003-04-15 Inhale Therapeutic Systems, Inc. Dry powder dispersing apparatus and methods for their use
US20030131847A1 (en) * 2002-01-16 2003-07-17 Fabrizio Niccolai Device usable in the treatment of affections of the airways
US20030150454A1 (en) * 2001-11-14 2003-08-14 Inhale Therapeutic Systems, Inc. Aerosolization apparatus with removable mouthpiece
EP1108439A3 (en) * 1999-12-15 2003-09-10 Ing. Erich Pfeiffer GmbH Product dispenser
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US20040077528A1 (en) * 1999-06-29 2004-04-22 Mannkind Corporation Purification and stabilization of peptide and protein pharmaceutical agents
US6732732B2 (en) 2001-04-16 2004-05-11 Advanced Inhalation Research, Inc. Inhalation device and method
US20040096403A1 (en) * 1995-05-15 2004-05-20 Mannkind Corporation Method for drug delivery to the pulmonary system
US20040182387A1 (en) * 1999-07-23 2004-09-23 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050028813A1 (en) * 2001-10-05 2005-02-10 Ian Harrison Apparatus for the nasal or oral delivery of a medicament
US20050088617A1 (en) * 2003-10-27 2005-04-28 Jen-Chuen Hsieh Method and apparatus for visual drive control
US20050153874A1 (en) * 2004-01-12 2005-07-14 Mannkind Corporation Method of reducing serum proinsulin levels in type 2 diabetics
US20050150492A1 (en) * 2003-04-09 2005-07-14 Nektar Therapeutics Aerosolization apparatus with air inlet shield
US20050177095A1 (en) * 2002-05-14 2005-08-11 Tatsuo Tsutsui Powder chemical feeding device for nasal cavity
US20050186146A1 (en) * 2004-02-12 2005-08-25 Nektar Therapeutics Interleukin-13 antagonist powders, spray-dried particles, and methods
US20050250705A1 (en) * 2004-05-10 2005-11-10 Boehringer Ingelheim Pharma Gmbh Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US20050250704A1 (en) * 2004-05-10 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US20050255119A1 (en) * 2004-05-10 2005-11-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US6978941B2 (en) 2001-05-02 2005-12-27 Aerogen, Inc. Base isolated nebulizing device and methods
US7032590B2 (en) 2001-03-20 2006-04-25 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US7032593B2 (en) 2000-08-14 2006-04-25 Advanced Inhalation Research, Inc. Inhalation device and method
US7040549B2 (en) 1991-04-24 2006-05-09 Aerogen, Inc. Systems and methods for controlling fluid feed to an aerosol generator
WO2006051300A1 (en) 2004-11-10 2006-05-18 Cipla Limited Inhaler
US7066398B2 (en) 1999-09-09 2006-06-27 Aerogen, Inc. Aperture plate and methods for its construction and use
US7112341B1 (en) 1999-04-13 2006-09-26 Nektar Therapeutics Pulmonary administration of dry powder formulations for treating infertility
US20070020191A1 (en) * 1999-06-29 2007-01-25 Mannkind Corporation Potentiation of glucose elimination
US7174888B2 (en) 1995-04-05 2007-02-13 Aerogen, Inc. Liquid dispensing apparatus and methods
US20070051362A1 (en) * 2004-04-23 2007-03-08 Sullivan Timothy R Multiple unit dose drug delivery system
US7195011B2 (en) 2001-03-20 2007-03-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US7201167B2 (en) 2004-04-20 2007-04-10 Aerogen, Inc. Method and composition for the treatment of lung surfactant deficiency or dysfunction
US20070086952A1 (en) * 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
WO2007098870A1 (en) * 2006-02-24 2007-09-07 Aha Kunststofftechnik Gmbh Dry powder inhaler
US20070209659A1 (en) * 1995-04-05 2007-09-13 Aerogen, Inc. Liquid dispensing apparatus and methods
US7290541B2 (en) 2004-04-20 2007-11-06 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US20070283955A1 (en) * 2006-06-07 2007-12-13 Bioactis Limites Peroral powder delivery device
US7322349B2 (en) 2000-05-05 2008-01-29 Aerogen, Inc. Apparatus and methods for the delivery of medicaments to the respiratory system
US20080039368A1 (en) * 2006-04-12 2008-02-14 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7331339B2 (en) 2000-05-05 2008-02-19 Aerogen, Inc. Methods and systems for operating an aerosol generator
US20080053437A1 (en) * 1999-07-23 2008-03-06 Mannkind Corporation Unit dose capsules and dry powder inhaler
US20080063606A1 (en) * 2001-12-19 2008-03-13 Tarara Thomas E Pulmonary delivery of aminoglycoside
US20080090753A1 (en) * 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
US7360536B2 (en) 2002-01-07 2008-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids for inhalation
US20080177246A1 (en) * 2007-01-09 2008-07-24 First City Tower Intranasal Cartridge Devices
US20080248999A1 (en) * 2007-04-04 2008-10-09 Biodel Inc. Amylin formulations
US20090025721A1 (en) * 2007-06-12 2009-01-29 Alkermes, Inc. Powder inhaler devices
US20090071108A1 (en) * 2007-09-14 2009-03-19 Mystic Pharmaceuticals, Inc. Deep draw container forming method
US20090090433A1 (en) * 2005-05-18 2009-04-09 Symyx Technologies Europe Sa Apparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts
US20090117193A1 (en) * 1999-10-29 2009-05-07 Nektar Therapeutics Compositions Comprising an Active Agent
US20090137455A1 (en) * 2005-09-29 2009-05-28 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20090175840A1 (en) * 2008-01-04 2009-07-09 Biodel, Inc. Insulin formulations for insulin release as a function of tissue glucose levels
US20090194105A1 (en) * 2006-04-13 2009-08-06 Jens Besseler Inhaler
US20090241949A1 (en) * 2008-03-27 2009-10-01 Smutney Chad C Dry powder inhalation system
US7600511B2 (en) 2001-11-01 2009-10-13 Novartis Pharma Ag Apparatus and methods for delivery of medicament to a respiratory system
US7628339B2 (en) 1991-04-24 2009-12-08 Novartis Pharma Ag Systems and methods for controlling fluid feed to an aerosol generator
US20090320838A1 (en) * 2006-06-16 2009-12-31 Cipla Limited Dry powder inhaler
US7669597B2 (en) 2007-05-16 2010-03-02 Mystic Pharmaceuticals, Inc. Combination unit dose dispensing containers
US7677467B2 (en) 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7771642B2 (en) 2002-05-20 2010-08-10 Novartis Ag Methods of making an apparatus for providing aerosol for medical treatment
US20100288275A1 (en) * 2007-04-05 2010-11-18 Optinose As Nasal administration
US20100287884A1 (en) * 2007-10-25 2010-11-18 Sangita Seshadri Powder conditioning of unit dose drug packages
US20100313886A1 (en) * 2007-08-01 2010-12-16 Herbert Wachtel Inhaler
US20110033544A1 (en) * 2009-05-15 2011-02-10 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetcs
US20110045088A1 (en) * 2009-07-31 2011-02-24 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US20110056488A1 (en) * 2008-01-24 2011-03-10 Vectura Delivery Devices Limited Inhaler
US7946291B2 (en) 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US20110171312A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Modified therapeutic peptides, methods of their preparation and use
WO2011163518A1 (en) 2010-06-24 2011-12-29 Gilead Sciences, Inc. Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
WO2012012776A1 (en) 2010-07-22 2012-01-26 Gilead Sciences, Inc. Methods and compounds for treating paramyxoviridae virus infections
WO2012037038A1 (en) 2010-09-13 2012-03-22 Gilead Sciences, Inc. 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US8357696B2 (en) 2005-05-18 2013-01-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
WO2013016787A1 (en) 2011-08-04 2013-02-07 Victor Esteve Powder inhaler
EP2594272A2 (en) 2005-05-18 2013-05-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8561609B2 (en) 2010-12-07 2013-10-22 Respira Therapeutics, Inc. Dry powder inhaler
WO2013158776A1 (en) 2012-04-17 2013-10-24 Gilead Sciences, Inc. Compounds and methods for antiviral treatment
US20130327327A1 (en) * 2012-06-06 2013-12-12 Aerodesigns, Inc. Aerosol dispenser with replaceable cartridge
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
US8623817B2 (en) 2008-08-11 2014-01-07 Mannkind Corporation Method of treating diabetes type 2 by administering ultrarapid acting insulin
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
US8664187B2 (en) 2004-06-18 2014-03-04 Novartis Ag Methods of treatment of endobronchial infections
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
US8683995B2 (en) 2007-05-16 2014-04-01 Mystic Pharmaceuticals, Inc. Dose dispensing containers
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8869794B1 (en) * 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
WO2015006838A1 (en) 2013-07-16 2015-01-22 Victor Esteve Powder inhaler
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US9108211B2 (en) 2005-05-25 2015-08-18 Nektar Therapeutics Vibration systems and methods
US9138410B2 (en) 2003-02-21 2015-09-22 Shin Nippon Biomedical Laboratories, Ltd. Compositions for nasal administration of pharmaceuticals
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
USD748242S1 (en) 2014-07-11 2016-01-26 H. Stuart Campbell Inhaler mouthpiece
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9248076B2 (en) 2007-05-16 2016-02-02 Mystic Pharmaceuticals, Inc. Dose dispensing containers
WO2016018697A1 (en) 2014-07-28 2016-02-04 Gilead Sciences, Inc. Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
USD752204S1 (en) 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752734S1 (en) 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
US20160095989A1 (en) * 2004-09-15 2016-04-07 Optinose As Nasal delivery devices
USD755367S1 (en) 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
US9346766B2 (en) 2004-08-20 2016-05-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9492625B2 (en) 2009-11-12 2016-11-15 Stc.Unm Dry powder inhaler with flutter dispersion member
US9550036B2 (en) 2011-03-03 2017-01-24 Impel Neuropharma Inc. Nasal drug delivery device
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
WO2017094027A1 (en) * 2015-12-01 2017-06-08 Cipla Limited Nasal spray assembly
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9682153B2 (en) 2008-09-19 2017-06-20 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
EP3210993A1 (en) 2012-03-13 2017-08-30 Gilead Sciences, Inc. 2'- substituted carba-nucleoside analogs for antiviral treatment
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9919117B2 (en) 2011-05-09 2018-03-20 Impel Neuropharma Inc. Nozzles for nasal drug delivery
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9993488B2 (en) 2014-02-20 2018-06-12 Otitopic Inc. Dry powder formulations for inhalation
US10016582B2 (en) 2008-02-07 2018-07-10 University Of Washington Through Its Center For Commercialization Circumferential aerosol device
US10028966B2 (en) 2014-01-10 2018-07-24 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK198591D0 (en) * 1991-12-10 1991-12-10 Novo Nordisk As Apparatus
DE19533979A1 (en) * 1995-09-14 1997-03-20 Alfred Von Schuckmann Device for the metered, airborne release of substances

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2307986A (en) * 1940-02-15 1943-01-12 Bolte Insufflator
US2517482A (en) * 1949-04-09 1950-08-01 Sharp & Dohme Inc Inhaler
US2519555A (en) * 1945-08-31 1950-08-22 Abbott Lab Sterile medicament insufflator cartridge and insufflator
US2581182A (en) * 1950-03-14 1952-01-01 Abbott Lab Inhaler
US2946332A (en) * 1957-12-23 1960-07-26 Nysco Lab Inc Insufflator
US3507277A (en) * 1966-09-17 1970-04-21 Fisons Pharmaceuticals Ltd Inhalation device
US3669113A (en) * 1966-03-07 1972-06-13 Fisons Ltd Inhalation device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2307986A (en) * 1940-02-15 1943-01-12 Bolte Insufflator
US2519555A (en) * 1945-08-31 1950-08-22 Abbott Lab Sterile medicament insufflator cartridge and insufflator
US2517482A (en) * 1949-04-09 1950-08-01 Sharp & Dohme Inc Inhaler
US2581182A (en) * 1950-03-14 1952-01-01 Abbott Lab Inhaler
US2946332A (en) * 1957-12-23 1960-07-26 Nysco Lab Inc Insufflator
US3669113A (en) * 1966-03-07 1972-06-13 Fisons Ltd Inhalation device
US3507277A (en) * 1966-09-17 1970-04-21 Fisons Pharmaceuticals Ltd Inhalation device

Cited By (267)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US4013075A (en) * 1974-07-15 1977-03-22 I.S.F. S.P.A. Inhalers and insufflators having a cutting means
US4240418A (en) * 1974-08-22 1980-12-23 Schering Aktiengesellschaft Apparatus for the inhalation of medicinal agents
US4105027A (en) * 1975-06-13 1978-08-08 Syntex Puerto Rico, Inc. Inhalation device
US4116195A (en) * 1976-02-10 1978-09-26 Allen & Hanburys Limited Device for dispensing medicaments
US4095596A (en) * 1976-11-26 1978-06-20 Smithkline Corporation Nasal inhaler
US4338931A (en) * 1979-04-27 1982-07-13 Claudio Cavazza Device for the quick inhalation of drugs in powder form by humans suffering from asthma
US4446862A (en) * 1979-10-30 1984-05-08 Baum Eric A Breath actuated devices for administering powdered medicaments
US4889114A (en) * 1983-12-17 1989-12-26 Boehringer Ingelheim Kg Powdered pharmaceutical inhaler
US4620847A (en) * 1984-06-01 1986-11-04 Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov Device for administering powdered substances
US4645487A (en) * 1984-06-05 1987-02-24 Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov Device for administering powdered substances
US4884565A (en) * 1987-08-17 1989-12-05 Miat S.P.A. Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
US5152284A (en) * 1989-02-23 1992-10-06 Phidea S.P.A. Disposable inhaler with pre-pierced capsule
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5033463A (en) * 1989-10-27 1991-07-23 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
US5617845A (en) * 1990-08-30 1997-04-08 Boehringer Ingelheim Kg Inhalation device free from propellent gas
US7040549B2 (en) 1991-04-24 2006-05-09 Aerogen, Inc. Systems and methods for controlling fluid feed to an aerosol generator
US7628339B2 (en) 1991-04-24 2009-12-08 Novartis Pharma Ag Systems and methods for controlling fluid feed to an aerosol generator
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5366122A (en) * 1991-08-27 1994-11-22 Ing. Erich Pfeiffer Gmbh & Co. Kg Dispenser for flowable media
US5460173A (en) * 1993-03-03 1995-10-24 Tenax Corporation Dry powder inhaler medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5488946A (en) * 1994-03-01 1996-02-06 Calhoun; Clifford A. Emergency breathing device for opening cartridges
US5653191A (en) * 1994-03-01 1997-08-05 Calhoun; Clifford A. Pressure indicator
US5715811A (en) * 1994-05-26 1998-02-10 Unisia Jecs Corporation Inhaling type medicine administering device and using method therefor
WO1996012513A1 (en) * 1994-10-24 1996-05-02 Oxford Biosciences Limited Particle delivery
US5901703A (en) * 1995-02-06 1999-05-11 Unisia Jecs Corporation Medicine administering device for nasal cavities
US5921236A (en) * 1995-03-10 1999-07-13 Unisia Jecs Corporation Medicine administering device for nasal cavities
EP0761248A4 (en) * 1995-03-10 1998-12-23 Unisia Jecs Corp Intranasal medicator
EP0761248A1 (en) * 1995-03-10 1997-03-12 Unisia Jecs Corporation Intranasal medicator
US8561604B2 (en) 1995-04-05 2013-10-22 Novartis Ag Liquid dispensing apparatus and methods
US20070209659A1 (en) * 1995-04-05 2007-09-13 Aerogen, Inc. Liquid dispensing apparatus and methods
US7174888B2 (en) 1995-04-05 2007-02-13 Aerogen, Inc. Liquid dispensing apparatus and methods
US20040096403A1 (en) * 1995-05-15 2004-05-20 Mannkind Corporation Method for drug delivery to the pulmonary system
US8394414B2 (en) 1995-05-15 2013-03-12 Mannkind Corporation Method for drug delivery to the pulmonary system
US6561186B2 (en) 1995-08-02 2003-05-13 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US6550477B1 (en) 1995-08-02 2003-04-22 Innovative Devices, Llc Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5692496A (en) * 1995-08-02 1997-12-02 Innovative Devices, Llc Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5823183A (en) * 1995-08-02 1998-10-20 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5988163A (en) * 1995-08-02 1999-11-23 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
US6209538B1 (en) * 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5810004A (en) * 1995-10-09 1998-09-22 Unisia Jecs Corporation Medicator for a capsule filled with a powdered drug
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
US5752505A (en) * 1996-03-21 1998-05-19 Unisia Jecs Corporation Inhalation-type medicine delivery device
US6186141B1 (en) * 1996-05-10 2001-02-13 Glaxo Wellcome Inc. Unit dose dispensing device
WO1998058695A1 (en) * 1997-06-23 1998-12-30 Marco Cecchini Inhaling device
US6341605B1 (en) * 1998-02-05 2002-01-29 Unisia Jecs Corporation Inhalant medicator
US6273086B1 (en) * 1998-02-06 2001-08-14 Unisia Jecs Corporation Inhalant medicator
US20030209243A1 (en) * 1998-06-04 2003-11-13 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US6901929B2 (en) 1998-06-04 2005-06-07 Nektar Therapeutics Dry powder dispersing apparatus and methods for their use
US7422013B2 (en) 1998-06-04 2008-09-09 Nektar Therapeutics Dry powder dispersing apparatus and methods for their use
US8161969B2 (en) 1998-06-04 2012-04-24 Novartis Ag Dry powder dispersing apparatus and methods for their use
US6546929B2 (en) 1998-06-04 2003-04-15 Inhale Therapeutic Systems, Inc. Dry powder dispersing apparatus and methods for their use
US20080230058A1 (en) * 1998-06-04 2008-09-25 Nektar Therapeutics Dry powder dispersing apparatus and methods for their use
US7112341B1 (en) 1999-04-13 2006-09-26 Nektar Therapeutics Pulmonary administration of dry powder formulations for treating infertility
US7648960B2 (en) 1999-06-29 2010-01-19 Mannkind Corporation Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles
US20070020191A1 (en) * 1999-06-29 2007-01-25 Mannkind Corporation Potentiation of glucose elimination
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US20110105391A1 (en) * 1999-06-29 2011-05-05 Mannkind Corporation Methods and Compositions for Delivering Peptides
US20040077528A1 (en) * 1999-06-29 2004-04-22 Mannkind Corporation Purification and stabilization of peptide and protein pharmaceutical agents
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US8889099B2 (en) 1999-06-29 2014-11-18 Mannkind Corporation Methods and compositions for delivering peptides
US20100086609A1 (en) * 1999-06-29 2010-04-08 Mannkind Corporation Methods and Compositions for Delivering Peptides
US8389470B2 (en) 1999-06-29 2013-03-05 Mannkind Corporation Methods and compositions for delivering peptides
US7943178B2 (en) 1999-06-29 2011-05-17 Mannkind Corporation Methods and compositions for delivering peptides
US20040182387A1 (en) * 1999-07-23 2004-09-23 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US8671937B2 (en) 1999-07-23 2014-03-18 Mannkind Corporation Unit dose capsules and dry powder inhaler
US8950397B2 (en) 1999-07-23 2015-02-10 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US9061111B2 (en) 1999-07-23 2015-06-23 Mannkind Corporation Unit dose capsules and dry powder inhaler
US8156936B2 (en) 1999-07-23 2012-04-17 Mannkind Corporation Unit dose capsules and dry powder inhaler
US20080190425A1 (en) * 1999-07-23 2008-08-14 Steiner Solomon S Unit dose cartridge and dry powder inhaler
US20080053437A1 (en) * 1999-07-23 2008-03-06 Mannkind Corporation Unit dose capsules and dry powder inhaler
US8215300B2 (en) 1999-07-23 2012-07-10 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US8398001B2 (en) 1999-09-09 2013-03-19 Novartis Ag Aperture plate and methods for its construction and use
US20070023547A1 (en) * 1999-09-09 2007-02-01 Aerogen, Inc. Aperture plate and methods for its construction and use
US7066398B2 (en) 1999-09-09 2006-06-27 Aerogen, Inc. Aperture plate and methods for its construction and use
US8501240B2 (en) 1999-10-29 2013-08-06 Novartis Ag Compositions comprising an active agent
US20090117193A1 (en) * 1999-10-29 2009-05-07 Nektar Therapeutics Compositions Comprising an Active Agent
EP1108439A3 (en) * 1999-12-15 2003-09-10 Ing. Erich Pfeiffer GmbH Product dispenser
US20010029947A1 (en) * 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US7748377B2 (en) 2000-05-05 2010-07-06 Novartis Ag Methods and systems for operating an aerosol generator
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US7322349B2 (en) 2000-05-05 2008-01-29 Aerogen, Inc. Apparatus and methods for the delivery of medicaments to the respiratory system
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US7331339B2 (en) 2000-05-05 2008-02-19 Aerogen, Inc. Methods and systems for operating an aerosol generator
US6923178B2 (en) 2000-05-10 2005-08-02 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet
US20050056281A1 (en) * 2000-05-10 2005-03-17 Snow John M. Medicament container with same side airflow inlet and outlet and method of use
US6948494B1 (en) 2000-05-10 2005-09-27 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet and method of use
US20020134382A1 (en) * 2000-05-10 2002-09-26 Snow John M. Medicament container with same side airflow inlet and outlet and method of use
US7318436B2 (en) 2000-05-10 2008-01-15 Innovative Devices, Llc Medicament container with same side airflow inlet and outlet and method of use
US7032593B2 (en) 2000-08-14 2006-04-25 Advanced Inhalation Research, Inc. Inhalation device and method
US8196573B2 (en) 2001-03-20 2012-06-12 Novartis Ag Methods and systems for operating an aerosol generator
US7195011B2 (en) 2001-03-20 2007-03-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US7100600B2 (en) * 2001-03-20 2006-09-05 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US7032590B2 (en) 2001-03-20 2006-04-25 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US20040154619A1 (en) * 2001-04-16 2004-08-12 Advanced Inhalation Research, Inc. Inhalation device and method
US20060283448A1 (en) * 2001-04-16 2006-12-21 Advanced Inhalation Research, Inc. Inhalation device and method
US7146978B2 (en) 2001-04-16 2006-12-12 Advanced Inhalation Research, Inc. Inhalation device and method
US7278425B2 (en) 2001-04-16 2007-10-09 Alkermes, Inc. Inhalation device and method
US20040216738A1 (en) * 2001-04-16 2004-11-04 Advanced Inhalation Research, Inc. Inhalation device and method
US6732732B2 (en) 2001-04-16 2004-05-11 Advanced Inhalation Research, Inc. Inhalation device and method
US20040154618A1 (en) * 2001-04-16 2004-08-12 Advanced Inhalation Research, Inc. Inhalation device and method
US7104463B2 (en) 2001-05-02 2006-09-12 Aerogen, Inc. Base isolated nebulizing device and methods
US6978941B2 (en) 2001-05-02 2005-12-27 Aerogen, Inc. Base isolated nebulizing device and methods
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US20050028813A1 (en) * 2001-10-05 2005-02-10 Ian Harrison Apparatus for the nasal or oral delivery of a medicament
US7163013B2 (en) * 2001-10-05 2007-01-16 Alchemy Healthcare Limited Apparatus for the nasal or oral delivery of a medicament
US7600511B2 (en) 2001-11-01 2009-10-13 Novartis Pharma Ag Apparatus and methods for delivery of medicament to a respiratory system
US20030150454A1 (en) * 2001-11-14 2003-08-14 Inhale Therapeutic Systems, Inc. Aerosolization apparatus with removable mouthpiece
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside
US20080063606A1 (en) * 2001-12-19 2008-03-13 Tarara Thomas E Pulmonary delivery of aminoglycoside
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US7360536B2 (en) 2002-01-07 2008-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids for inhalation
US7677467B2 (en) 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
US8539944B2 (en) 2002-01-07 2013-09-24 Novartis Ag Devices and methods for nebulizing fluids for inhalation
US20030131847A1 (en) * 2002-01-16 2003-07-17 Fabrizio Niccolai Device usable in the treatment of affections of the airways
US6705313B2 (en) * 2002-01-16 2004-03-16 Ph&T S.P.A. Device usable in the treatment of affections of the airways
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US7353823B2 (en) * 2002-05-14 2008-04-08 Bioactis Limited Powder chemical feeding device for nasal cavity
US20050177095A1 (en) * 2002-05-14 2005-08-11 Tatsuo Tsutsui Powder chemical feeding device for nasal cavity
US7771642B2 (en) 2002-05-20 2010-08-10 Novartis Ag Methods of making an apparatus for providing aerosol for medical treatment
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US9138410B2 (en) 2003-02-21 2015-09-22 Shin Nippon Biomedical Laboratories, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
US20090260623A1 (en) * 2003-04-09 2009-10-22 Novartis Pharma Ag Aeorosolization apparatus with air inlet shield
US8069851B2 (en) 2003-04-09 2011-12-06 Novartis Ag Aeorosolization apparatus with air inlet shield
US20050150492A1 (en) * 2003-04-09 2005-07-14 Nektar Therapeutics Aerosolization apparatus with air inlet shield
US7559325B2 (en) 2003-04-09 2009-07-14 Novartis Pharma Ag Aerosolization apparatus with air inlet shield
US8869794B1 (en) * 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
US20050088617A1 (en) * 2003-10-27 2005-04-28 Jen-Chuen Hsieh Method and apparatus for visual drive control
US20050153874A1 (en) * 2004-01-12 2005-07-14 Mannkind Corporation Method of reducing serum proinsulin levels in type 2 diabetics
US20050186146A1 (en) * 2004-02-12 2005-08-25 Nektar Therapeutics Interleukin-13 antagonist powders, spray-dried particles, and methods
US8933023B2 (en) 2004-03-12 2015-01-13 Biodel Inc. Rapid acting injectable insulin compositions
US20080090753A1 (en) * 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
US20090192075A1 (en) * 2004-03-12 2009-07-30 Biodel Inc. Amylin Formulations
US7267121B2 (en) 2004-04-20 2007-09-11 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7946291B2 (en) 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
US7290541B2 (en) 2004-04-20 2007-11-06 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7201167B2 (en) 2004-04-20 2007-04-10 Aerogen, Inc. Method and composition for the treatment of lung surfactant deficiency or dysfunction
US20070051362A1 (en) * 2004-04-23 2007-03-08 Sullivan Timothy R Multiple unit dose drug delivery system
US20050250704A1 (en) * 2004-05-10 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US20050250705A1 (en) * 2004-05-10 2005-11-10 Boehringer Ingelheim Pharma Gmbh Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7727962B2 (en) 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US7723306B2 (en) 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7611709B2 (en) 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US20050255119A1 (en) * 2004-05-10 2005-11-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US8664187B2 (en) 2004-06-18 2014-03-04 Novartis Ag Methods of treatment of endobronchial infections
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9346766B2 (en) 2004-08-20 2016-05-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US20160095989A1 (en) * 2004-09-15 2016-04-07 Optinose As Nasal delivery devices
WO2006051300A1 (en) 2004-11-10 2006-05-18 Cipla Limited Inhaler
US20080105256A1 (en) * 2004-11-10 2008-05-08 Cipla Limited Inhaler
US8006695B2 (en) 2004-11-10 2011-08-30 Cipla Limited Inhaler
US20110183901A1 (en) * 2005-03-31 2011-07-28 Mannkind Corporation Superior Control of Blood Glucose in Diabetes Treatment
US8357696B2 (en) 2005-05-18 2013-01-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20090090433A1 (en) * 2005-05-18 2009-04-09 Symyx Technologies Europe Sa Apparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts
EP2594272A2 (en) 2005-05-18 2013-05-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US9108211B2 (en) 2005-05-25 2015-08-18 Nektar Therapeutics Vibration systems and methods
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20090137455A1 (en) * 2005-09-29 2009-05-28 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20070086952A1 (en) * 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
KR101150000B1 (en) 2006-02-24 2012-06-01 아하 쿤스트스트오프테크니크 게엠베하 Dry powder inhaler
US20110120463A1 (en) * 2006-02-24 2011-05-26 Victor Esteve Dry powder inhaler
CN101389367B (en) 2006-02-24 2011-10-05 阿哈塑料技术有限公司 Dry powder inhaler
WO2007098870A1 (en) * 2006-02-24 2007-09-07 Aha Kunststofftechnik Gmbh Dry powder inhaler
US8539946B2 (en) 2006-02-24 2013-09-24 Eric Zembrod Dry powder inhaler
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20080039368A1 (en) * 2006-04-12 2008-02-14 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7718609B2 (en) 2006-04-12 2010-05-18 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20090194105A1 (en) * 2006-04-13 2009-08-06 Jens Besseler Inhaler
US8584669B2 (en) 2006-04-13 2013-11-19 Boehringer Ingelheim International Gmbh Inhaler
US7806117B2 (en) * 2006-06-07 2010-10-05 Shin Nippon Biomedical Laboratories, Ltd. Peroral powder delivery device
US20070283955A1 (en) * 2006-06-07 2007-12-13 Bioactis Limites Peroral powder delivery device
US8522775B2 (en) * 2006-06-16 2013-09-03 Cipla Limited Dry powder inhaler
US20090320838A1 (en) * 2006-06-16 2009-12-31 Cipla Limited Dry powder inhaler
US8377009B2 (en) 2007-01-09 2013-02-19 Mystic Pharmaceuticals, Inc. Intranasal cartridge devices
US20080177246A1 (en) * 2007-01-09 2008-07-24 First City Tower Intranasal Cartridge Devices
US20080248999A1 (en) * 2007-04-04 2008-10-09 Biodel Inc. Amylin formulations
US8875704B2 (en) 2007-04-05 2014-11-04 Optinose As Nasal administration
US9649456B2 (en) * 2007-04-05 2017-05-16 Optinose As Nasal administration
US20100288275A1 (en) * 2007-04-05 2010-11-18 Optinose As Nasal administration
US9248076B2 (en) 2007-05-16 2016-02-02 Mystic Pharmaceuticals, Inc. Dose dispensing containers
US9592354B2 (en) 2007-05-16 2017-03-14 Mystic Pharmaceuticals, Inc. Combination unit dose dispensing containers
US8683995B2 (en) 2007-05-16 2014-04-01 Mystic Pharmaceuticals, Inc. Dose dispensing containers
US7669597B2 (en) 2007-05-16 2010-03-02 Mystic Pharmaceuticals, Inc. Combination unit dose dispensing containers
US8496002B2 (en) 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
US20090025721A1 (en) * 2007-06-12 2009-01-29 Alkermes, Inc. Powder inhaler devices
CN101815552B (en) 2007-08-01 2013-03-06 贝林格尔.英格海姆国际有限公司 Inhalers
US8919342B2 (en) 2007-08-01 2014-12-30 Boehringer Ingelheim International Gmbh Inhaler
US20100313886A1 (en) * 2007-08-01 2010-12-16 Herbert Wachtel Inhaler
US7963089B2 (en) 2007-09-14 2011-06-21 Mystic Pharmaceuticals, Inc. Deep draw container forming method
US20090071108A1 (en) * 2007-09-14 2009-03-19 Mystic Pharmaceuticals, Inc. Deep draw container forming method
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
US20100287884A1 (en) * 2007-10-25 2010-11-18 Sangita Seshadri Powder conditioning of unit dose drug packages
US20090175840A1 (en) * 2008-01-04 2009-07-09 Biodel, Inc. Insulin formulations for insulin release as a function of tissue glucose levels
US9125998B2 (en) 2008-01-24 2015-09-08 Vectura Delivery Devices Limited Inhaler
US20110056488A1 (en) * 2008-01-24 2011-03-10 Vectura Delivery Devices Limited Inhaler
US10016582B2 (en) 2008-02-07 2018-07-10 University Of Washington Through Its Center For Commercialization Circumferential aerosol device
US20090241949A1 (en) * 2008-03-27 2009-10-01 Smutney Chad C Dry powder inhalation system
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US8623817B2 (en) 2008-08-11 2014-01-07 Mannkind Corporation Method of treating diabetes type 2 by administering ultrarapid acting insulin
US9682153B2 (en) 2008-09-19 2017-06-20 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US20110171312A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Modified therapeutic peptides, methods of their preparation and use
US9717738B2 (en) 2008-10-07 2017-08-01 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9326936B2 (en) 2008-10-07 2016-05-03 Raptor Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US20110033544A1 (en) * 2009-05-15 2011-02-10 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetcs
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US20110045088A1 (en) * 2009-07-31 2011-02-24 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9492625B2 (en) 2009-11-12 2016-11-15 Stc.Unm Dry powder inhaler with flutter dispersion member
WO2011163518A1 (en) 2010-06-24 2011-12-29 Gilead Sciences, Inc. Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
EP3012258A1 (en) 2010-06-24 2016-04-27 Gilead Sciences, Inc. Pyrazolo[1,5-a]pyrimidines and -triazines as antiviral agents
WO2012012776A1 (en) 2010-07-22 2012-01-26 Gilead Sciences, Inc. Methods and compounds for treating paramyxoviridae virus infections
WO2012037038A1 (en) 2010-09-13 2012-03-22 Gilead Sciences, Inc. 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
US8651104B2 (en) 2010-12-07 2014-02-18 Respira Therapeutics, Inc. Bead-containing dry powder inhaler
US8561609B2 (en) 2010-12-07 2013-10-22 Respira Therapeutics, Inc. Dry powder inhaler
US9550036B2 (en) 2011-03-03 2017-01-24 Impel Neuropharma Inc. Nasal drug delivery device
US9919117B2 (en) 2011-05-09 2018-03-20 Impel Neuropharma Inc. Nozzles for nasal drug delivery
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
WO2013016787A1 (en) 2011-08-04 2013-02-07 Victor Esteve Powder inhaler
WO2013016784A1 (en) 2011-08-04 2013-02-07 Victor Esteve Dry powder inhaler
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
EP3210993A1 (en) 2012-03-13 2017-08-30 Gilead Sciences, Inc. 2'- substituted carba-nucleoside analogs for antiviral treatment
WO2013158776A1 (en) 2012-04-17 2013-10-24 Gilead Sciences, Inc. Compounds and methods for antiviral treatment
US9845187B2 (en) * 2012-06-06 2017-12-19 Aerodesigns, Inc. Aerosol dispenser with replaceable cartridge
US20130327327A1 (en) * 2012-06-06 2013-12-12 Aerodesigns, Inc. Aerosol dispenser with replaceable cartridge
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
WO2015006838A1 (en) 2013-07-16 2015-01-22 Victor Esteve Powder inhaler
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10028966B2 (en) 2014-01-10 2018-07-24 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US9993488B2 (en) 2014-02-20 2018-06-12 Otitopic Inc. Dry powder formulations for inhalation
USD752734S1 (en) 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
USD752204S1 (en) 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
USD755367S1 (en) 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
USD748242S1 (en) 2014-07-11 2016-01-26 H. Stuart Campbell Inhaler mouthpiece
WO2016018697A1 (en) 2014-07-28 2016-02-04 Gilead Sciences, Inc. Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections
WO2017094027A1 (en) * 2015-12-01 2017-06-08 Cipla Limited Nasal spray assembly

Also Published As

Publication number Publication date Type
FR2224175B1 (en) 1978-04-14 grant
BE813143A (en) 1974-07-31 grant
DE2415961A1 (en) 1974-10-17 application
BE813143A1 (en) grant
JPS5048782A (en) 1975-05-01 application
DE7411543U (en) 1976-02-05 grant
FR2224175A1 (en) 1974-10-31 application
GB1436813A (en) 1976-05-26 application

Similar Documents

Publication Publication Date Title
US3425414A (en) Inhalant dispenser
US3376866A (en) Medicament injector with attached vial
US3552387A (en) Combination syringe and vial
US3605744A (en) Injection apparatus and method of injecting
US3348546A (en) Intermixing syringe
US3342180A (en) Disposable liquid-powder package and hypodermic syringe
US3518992A (en) Oral inhaler with spring biased,cam driven piercing device
US3306290A (en) Automatically retractable needle syringe
US3089490A (en) Disposable cartridge type hypodermic syringes
US4838863A (en) Safe needle system for collecting fluids
US4946446A (en) Retractable needle
US5620421A (en) Syringe injector system
US2956563A (en) Hypodermic syringe devices
US5137516A (en) Triggered application device for medicament to be more descriptive of the invention
US4515267A (en) Dental mixing and extrusion capsule
US4592745A (en) Dispenser
US6221044B1 (en) Automatic injection device
US4117844A (en) Device for dispensing medicaments
US2752918A (en) Hypodermic injection apparatus
US5273541A (en) Safety syringe
US4235235A (en) Syringe
US5681323A (en) Emergency cricothyrotomy tube insertion
US4444560A (en) Dental instrument-PDL syringe
US2221739A (en) Hypodermic syringe
US3527212A (en) Disposable needleless hypodermic injector